Phthisis Bulbi

Phthisis bulbi means an eye has become shrunken, scarred, and permanently blind after severe damage or long-standing disease. It is usually irreversible. Care focuses on comfort (pain control and dryness), safety (protecting the healthy eye), and appearance (prosthesis). Surgery is offered when the eye is painful or cosmetic concerns are significant.

Phthisis bulbi (pronounced THY-sis BUL-bee) is a medical term for an eye that has lost its normal shape, pressure, and function after major injury or disease. The eye becomes small and soft because the inner tissues are badly scarred, the fluid system collapses, and the outer wall thickens and may calcify. Vision is usually absent in that eye. The condition itself is not an infection or a cancer; it is the end-stage result of many possible problems such as severe trauma, infections, long-standing inflammation (uveitis), retinal detachment, tumors, poor wound healing, or untreated glaucoma.

Phthisis bulbi is the term doctors use for an end-stage, shrunken, scarred, and non-working eye. It is not a new disease by itself. It is the final result of many different severe eye problems that were very long-standing, very damaging, or both. In phthisis bulbi, the eye becomes small, soft or sometimes stony-hard in places, and the inside structures are destroyed or fused by scar tissue. The ciliary body (the part that makes eye fluid) stops working, so the eye often has very low pressure (chronic hypotony). The retina and choroid (the light-sensing and nourishing layers) become thin, folded, or detached. The cornea (the clear window) may turn opaque, white, or irregular, and the front chamber can become very shallow or even closed by scarring. Over time, calcium deposits and even bone-like tissue (ossification) can form inside the eye. Because the eye is no longer healthy, it cannot see or sees only light/dark at best. The eye may be painless and quiet, or it may stay chronically red and painful if inflammation or pressure spikes occur.

In short, phthisis bulbi is the end of the road for an eye that has suffered severe injury, infection, inflammation, or advanced disease. The goal of care at this stage is comfort, safety, and appearance, and to make sure the other eye is protected and healthy.

---

Pathophysiology

Many different problems can lead to the same end point:

1. Long-term low eye pressure (chronic hypotony) happens when the ciliary body is damaged (by inflammation, trauma, surgery complications, or scarring). With too little fluid being made, the eye slowly collapses inward, causing wrinkling of tissues and shrinkage of the globe.

2. Cyclitic membranes (scar sheets inside the eye) can pull on the ciliary body and retina, worsen hypotony, and cause traction retinal detachment and internal disorganization.

3. Chronic inflammation or infection keeps releasing damaging enzymes and inflammatory chemicals, which scar, thin, and calcify the inner layers.

4. Tissue death and healing lead to fibrosis, pigment migration, calcification, and sometimes ossification, turning parts of the eye chalky or bone-like.

5. The eye’s structures—cornea, iris, lens, ciliary body, retina, choroid, and sclera—lose their normal shape and function. The pupil may be stuck, the lens may be absorbed, the retina may be folded, and the sclera may thicken and buckle.

The final picture is an eye that is small, scarred, and functionally blind.

---

Types of phthisis bulbi

A. By clinical–pathologic stage

1. Pre-phthisical (chronic hypotony) stage
   The eye pressure is consistently low, vision is poor, and there is ongoing inflammation or scarring, but the eye has not yet fully shrunken.

2. Phthisis bulbi (established)
   The eye is visibly smaller, hard or soft in abnormal ways, opaque, and internally disorganized. Vision is minimal or absent.

3. Phthisis bulbi with calcification/ossification (end-stage)
   Calcium and sometimes bone-like tissue form inside the eye. The globe may feel irregular and firm in places and is irreversibly blind.

B. By underlying cause (etiologic types)

1. Traumatic (penetrating, blunt, or ruptured globe)

2. Infectious (severe keratitis, endophthalmitis, panophthalmitis)

3. Inflammatory/autoimmune (chronic uveitis, sympathetic ophthalmia)

4. Vascular/ischemic (very poor blood supply to eye tissues)

5. Neoplastic/treated tumors (tissue loss after tumor therapy)

6. Iatrogenic/surgical (over-filtration, cyclodialysis, surgical complications)

7. Toxic/chemical/thermal (burns and toxic damage)

8. Developmental/pediatric (end-stage of severe early eye disease)
   These categories overlap; many eyes have more than one contributing factor.

---

Common causes

1. Penetrating or perforating injury
   A sharp object enters the eye, causing massive internal damage, infection risk, and scarring that eventually shrinks the eye.

2. Ruptured globe from blunt trauma
   A hard blow splits the eye wall, leading to tissue loss, infection, and poor healing that ends in phthisis.

3. Severe, untreated corneal ulcer with perforation
   A deep infection creates a hole in the cornea, allowing collapse, infection spread, and scarring that destroys the eye’s structure.

4. Post-infectious endophthalmitis
   Infection inside the eye after surgery, injury, or bloodstream spread can overwhelm tissues, leaving dense scars and no function.

5. Panophthalmitis
   A whole-eye infection involving all coats of the eye causes rapid tissue death, leading to shrinkage after healing.

6. Chronic, uncontrolled uveitis
   Long-standing inflammation shuts down the ciliary body, creates scar membranes, and starves the retina.

7. Sympathetic ophthalmia (rare)
   After a severe injury to one eye, the immune system attacks both eyes. If the damaged eye is not controlled, it can become phthisical.

8. Over-filtration after glaucoma surgery
   Too much fluid escapes the eye, pressure stays very low, and the eye collapses over time.

9. Cyclodialysis cleft
   A tear that opens an abnormal drainage pathway makes pressure chronically low, leading to hypotony and shrinkage.

10. Long-standing retinal detachment with proliferative scarring
    The retina is off for a long time and scar tissue pulls on internal structures, promoting collapse and disorganization.

11. Radiation damage
    Radiation used for eye tumors can injure blood vessels and ciliary body, leading to hypotony and fibrosis.

12. Chemical burns (alkali or acid)
    Chemicals kill corneal and limbal stem cells, cause deep inflammation, and later scarring that ends in phthisis.

13. Severe thermal injury
    Intense heat causes coagulation of tissues, poor healing, and end-stage shrinkage.

14. Advanced uncontrolled glaucoma
    Very high pressure can destroy tissues and later the eye can go into hypotony and atrophy after damage to the ciliary body.

15. Severe scleritis (especially necrotizing)
    The white of the eye thins and dies in spots; the eye becomes structurally unstable and shrunken.

16. Intraocular foreign body with chronic inflammation
    A retained object keeps the eye inflamed and toxic, leading to scars and collapse.

17. Severe diabetic or ischemic eye with neovascular complications
    Poor blood supply and abnormal vessels lead to chronic inflammation, bleeding, and shutdown of fluid production.

18. Untreated or late-treated pediatric diseases (e.g., advanced retinopathy of prematurity, persistent fetal vasculature)
    These can progress to disorganized, small, blind eyes.

19. Tumor-related tissue loss (e.g., after treatment for retinoblastoma or melanoma)
    Aggressive disease and its treatment may leave an eye non-functional, later becoming phthisical.

20. Chronic hypotony after complicated eye surgery (multiple types)
    Repeated operations or complications can injure the ciliary body, leaving the eye permanently low-pressure and shrunken.

---

Symptoms and signs

1. Very poor vision or no light perception
   The eye cannot form an image. Sometimes only light vs dark is felt.

2. Eye looks smaller than the other eye
   Family and friends may notice the eye is sunken or reduced in size.

3. Chronic redness
   The eye can stay red due to ongoing low-grade inflammation.

4. Dull, aching eye pain or tenderness
   Pain may be constant or on touch, especially if inflammation flares.

5. Tearing or discharge
   The eye may water or produce mucus.

6. White or cloudy cornea
   The front window turns white/opaque from scarring or calcium.

7. Irregular, distorted pupil
   The pupil may be stuck, oval, or covered by scar tissue.

8. Shallow or closed anterior chamber
   The space in front of the iris can look flattened.

9. Visible white plaques or chalky areas
   These are calcium deposits or ossified areas.

10. Cosmetic asymmetry
    The appearance can affect self-confidence and social comfort.

11. Sensitivity to light
    Even with poor vision, the eye can be photophobic if inflamed.

12. Headache around the eye
    Pain can refer to the forehead or cheek.

13. Limited eye movements
    Scarring may restrict movements, causing discomfort or double vision in some positions.

14. Eyelids may look droopy or tight
    Soft-tissue changes can make the lids droop or the eye look sunken.

15. Visible scar on the cornea or sclera
    Old injury sites may be obvious on close look.

---

Diagnostic tests

A) Physical exam

1. Visual acuity with pinhole
   Even if vision is very poor, checking any remaining acuity and with a pinhole helps document baseline and confirms end-stage status.

2. Pupillary light reflex and relative afferent pupil defect (RAPD) check
   The pupil’s in–out light reaction shows if the optic nerve/retina can still carry signals. In phthisis, responses are often absent.

3. External inspection and ocular alignment/motility exam
   The doctor looks for size difference, enophthalmos, lid changes, and tests eye movements to note restriction or pain.

4. Slit-lamp biomicroscopy
   This detailed microscope exam shows corneal opacity, anterior chamber depth, iris scarring, membranes, and surface calcium.

B) Manual tests

5. Digital palpation of intraocular pressure
   Gently pressing both eyes (with lids closed) helps estimate if the eye is very soft (hypotony) or abnormally firm from calcification.

6. Seidel test with fluorescein
   A simple dye test checks for leaks in cases with old perforation sites or thin scars that might still ooze aqueous.

7. Confrontation visual fields
   A bedside mapping of any remaining field of vision, often severely constricted or absent in a phthisical eye.

8. Cotton-wisp corneal sensitivity test
   Touching the cornea lightly checks nerve function; it is often reduced or absent due to scarring.

C) Lab & pathological studies

9. Corneal/aqueous/vitreous cultures and smears (Gram stain, KOH)
   If active infection is suspected, samples help identify germs to guide treatment and prevent painful flares.

10. Complete blood count, ESR/CRP
    These basic tests look for systemic infection or inflammation, helpful when scleritis or uveitis is part of the story.

11. Autoimmune/infectious panels when indicated (e.g., ANA, ANCA, HLA-B27, ACE/lysozyme for sarcoid, syphilis serology, TB testing)
    These tests look for diseases that drive chronic eye inflammation, which may have caused or worsened the damage.

12. Cytology/histopathology of ocular tissue (often after enucleation)
    When the eye is removed for pain or tumor suspicion, the tissue exam confirms calcification, ossification, scarring, and rules out malignancy.

D) Electrodiagnostic tests

13. Full-field electroretinography (ERG)
    Measures the electrical response of the retina; in phthisis, the signal is often very reduced or extinguished.

14. Visual evoked potentials (VEP)
    Checks the signal from eye to brain. If no usable signal reaches the brain, it supports end-stage dysfunction.

15. Electro-oculography (EOG)
    Assesses retinal pigment epithelium and eye movement–related potentials; usually poor in a severely damaged eye.

16. Oculomotor recording/EMG (selected cases)
    Rarely needed, but can document restricted or abnormal movements if scar tethering is suspected.

E) Imaging

17. B-scan ocular ultrasonography
    Works through opaque corneas to show retinal detachment, membranes, calcification, or intraocular foreign bodies when the view is blocked.

18. Ultrasound biomicroscopy (UBM)
    High-resolution ultrasound of the front of the eye shows ciliary body atrophy, cyclitic membranes, and cyclodialysis clefts.

19. CT scan of the orbits
    Excellent for calcification, ossification, metallic foreign bodies, and bony changes; helps surgical planning.

20. MRI of the orbits
    Shows soft-tissue detail, inflammation, tumors, and optic nerve/pathway status; used when CT is inconclusive or no metal is present.

Non-pharmacological treatments (therapies and “others”)

Below are non-drug options. For each, you’ll see Description, Purpose, and Mechanism (how it helps).

1. Protective eyewear for the healthy eye
   Description: Daily use of impact-rated glasses whenever you work, play sports, or use tools.
   Purpose: Prevents injury to the only seeing eye.
   Mechanism: Polycarbonate lenses absorb blows and block projectiles and UV.

2. Monocular safety training
   Description: Teaching depth-perception strategies, head turns, and scanning.
   Purpose: Lowers risk of falls, bumps, and driving errors.
   Mechanism: Trains the brain to compensate for lost stereovision.

3. Scleral shell / cosmetic prosthesis (without surgery)
   Description: A thin custom “shell” worn over a quiet phthisical eye.
   Purpose: Restores symmetric appearance; can also reduce tearing.
   Mechanism: Covers surface irregularities and improves eyelid mechanics.

4. Custom prosthetic eye after prior surgery
   Description: If the eye was removed in the past, a certified ocularist fits a custom prosthesis.
   Purpose: Natural look, improved eyelid support, and tear flow.
   Mechanism: Precisely matched shape and color distribute lid forces evenly.

5. Moisture chamber glasses
   Description: Wraparound glasses that trap humidity.
   Purpose: Relieves dryness, burning, and wind sensitivity.
   Mechanism: Creates a humid pocket to slow tear evaporation.

6. Warm compress and eyelid massage
   Description: Clean, warm (not hot) compress 5–10 minutes, then gentle lid massage.
   Purpose: Eases dry eye from oil gland blockage.
   Mechanism: Melts thick meibum so tears spread smoothly.

7. Eyelid hygiene (lid scrubs)
   Description: Daily cleaning with diluted baby shampoo or commercial pads.
   Purpose: Reduces inflammation and crusting that worsen dryness.
   Mechanism: Removes bacteria/biofilm that irritate eyelid margins.

8. Cold compress for flare-ups
   Description: Clean, cool compress for 5 minutes when redness or aching spikes.
   Purpose: Calms pain and swelling.
   Mechanism: Cold narrows surface blood vessels and dampens nerve signals.

9. Punctal plugs (office procedure, no drugs)
   Description: Tiny silicone stoppers placed in the tear drains.
   Purpose: Keeps natural tears on the eye longer.
   Mechanism: Reduces tear outflow to increase moisture.

10. Bandage or scleral contact lens (therapeutic device)
    Description: Special lenses fitted by an eye specialist.
    Purpose: Protects the cornea and improves comfort.
    Mechanism: Shields nerve endings and smooths the surface.

11. Retrobulbar alcohol or chlorpromazine injection (pain control procedure)
    Description: One-time targeted injection behind the painful eye.
    Purpose: Stops severe eye pain when other methods fail and surgery is not desired.
    Mechanism: Temporarily disables the pain nerve pathways.

12. Low-vision rehabilitation (for the seeing eye if needed)
    Description: Training and tools (magnifiers, lighting, large-print devices).
    Purpose: Maximizes function if the fellow eye has any visual limits.
    Mechanism: Adapts tasks and environments to remaining vision.

13. Home safety modifications
    Description: Extra lighting, high-contrast edges on steps, clear walkways.
    Purpose: Prevents falls and injuries.
    Mechanism: Improves visibility and reduces tripping hazards for monocular living.

14. Driving assessment and strategy
    Description: Professional evaluation and practice (if legal and safe).
    Purpose: Ensures safe driving with one eye.
    Mechanism: Tests reaction time, scanning, and mirror use; teaches compensatory techniques.

15. Workplace and school accommodations
    Description: Seating, screen position, font size, and rest breaks.
    Purpose: Reduces eye strain and improves productivity.
    Mechanism: Ergonomic adjustments match your visual needs.

16. Stress reduction and pain coping skills
    Description: Breathing, mindfulness, CBT-based methods.
    Purpose: Lowers the stress-pain cycle and improves sleep.
    Mechanism: Activates parasympathetic pathways and reframes pain signals.

17. Smoking cessation
    Description: Fully stopping tobacco/Nicotine.
    Purpose: Reduces inflammation and improves healing.
    Mechanism: Removes oxidative and vascular stress that worsens ocular surface disease.

18. UV-blocking sunglasses
    Description: 100% UVA/UVB sunglasses outdoors.
    Purpose: Reduces light sensitivity and surface irritation.
    Mechanism: Filters UV/blue light that can trigger discomfort.

19. Avoid eye rubbing and irritants
    Description: Keep hands clean, avoid fumes, dust, strong cleaners.
    Purpose: Prevents micro-injuries and flare-ups.
    Mechanism: Reduces mechanical and chemical stress to fragile tissues.

20. Peer support and counseling
    Description: Support groups or counseling for appearance or vision loss concerns.
    Purpose: Addresses anxiety, grief, or stigma.
    Mechanism: Shared strategies and professional guidance improve resilience.

Note: Non-drug options improve comfort and safety; they do not restore vision in a phthisical eye.

---

Drug treatments

These medicines treat symptoms or underlying inflammation, not the structural shrinkage itself. Always follow your eye specialist’s instructions.

1. Preservative-free artificial tears (lubricating drops/gel/ointment)
   Class: Ocular lubricants.
   Dosage/Time: Drops or gel 4–8×/day as needed; ointment at bedtime.
   Purpose: Relieve dryness, burning, and foreign-body sensation.
   Mechanism: Supplements the tear film and protects the cornea.
   Side effects: Temporary blur; rare allergy, especially with preservatives (hence preservative-free preferred).

2. Topical corticosteroid drops (e.g., prednisolone acetate 1%)
   Class: Anti-inflammatory steroid.
   Dosage/Time: 1 drop 2–4×/day for short courses only, then taper (per doctor).
   Purpose: Calm surface or intraocular inflammation during flares.
   Mechanism: Blocks inflammatory chemical pathways.
   Side effects: ↑ eye pressure, cataract risk, delayed healing, infection risk—needs medical monitoring.

3. Cycloplegic/mydriatic drops (e.g., atropine 1% or cyclopentolate 1%)
   Class: Anticholinergic.
   Dosage/Time: Typically 1 drop 1–2×/day in painful spasms.
   Purpose: Reduces ciliary muscle spasm pain and light sensitivity.
   Mechanism: Temporarily paralyzes the focusing muscle and dilates the pupil.
   Side effects: Light sensitivity, near-blur; avoid systemic ingestion in children.

4. Topical NSAID drops (e.g., ketorolac 0.5%)
   Class: Non-steroidal anti-inflammatory.
   Dosage/Time: 1 drop 2–4×/day short-term.
   Purpose: Extra pain control on the surface.
   Mechanism: Inhibits prostaglandins.
   Side effects: Stinging; rare corneal issues with prolonged use.

5. IOP-lowering drops (if pressure is high and painful)
   Class: Beta-blockers (timolol), alpha-agonists (brimonidine), CAIs (dorzolamide).
   Dosage/Time: Usually 1 drop 1–2×/day depending on agent.
   Purpose: Reduces pressure-related pain.
   Mechanism: Lowers aqueous production or increases outflow.
   Side effects: Depends on class (e.g., bradycardia with beta-blockers, fatigue with brimonidine); doctor will screen.

6. Topical antibiotic drops/ointment (e.g., moxifloxacin, erythromycin)
   Class: Antibacterial.
   Dosage/Time: Per infection risk or actual infection, several times/day for 5–7 days.
   Purpose: Treat or prevent surface infection if the cornea is compromised.
   Mechanism: Kills or inhibits bacteria.
   Side effects: Irritation; allergy is rare.

7. Oral NSAIDs (e.g., ibuprofen, naproxen)
   Class: Systemic non-steroidal anti-inflammatory.
   Dosage/Time: E.g., ibuprofen 200–400 mg every 6–8 h with food (doctor-advised).
   Purpose: Pain relief during flares.
   Mechanism: Blocks COX enzymes and prostaglandins.
   Side effects: Stomach upset, bleeding risk, kidney strain; avoid with ulcers or certain heart/kidney conditions.

8. Neuropathic pain modulators (e.g., gabapentin or amitriptyline)
   Class: Anticonvulsant / tricyclic antidepressant.
   Dosage/Time: Gabapentin often 100–300 mg at night then titrated; amitriptyline 10–25 mg at night (doctor-guided).
   Purpose: Treat nerve-type eye/orbital pain not controlled by simple analgesics.
   Mechanism: Dampen abnormal nerve firing and pain signaling.
   Side effects: Drowsiness, dizziness, dry mouth; start low and go slow.

9. Short course oral corticosteroid (e.g., prednisone)
   Class: Systemic steroid.
   Dosage/Time: Doctor-directed taper for acute inflammatory flare.
   Purpose: Quickly suppresses severe inflammation around the phthisical eye.
   Mechanism: Potent cytokine suppression.
   Side effects: Sugar elevation, mood change, sleep issues, infection risk; requires supervision.

10. Immunomodulators for underlying uveitis (e.g., methotrexate, mycophenolate)*
    Class: Steroid-sparing systemic immunotherapy.
    Dosage/Time: Weekly (methotrexate) or daily (mycophenolate) per specialist.
    Purpose: Control systemic or ocular inflammation to protect the other eye and prevent new damage.
    Mechanism: Tames overactive immune cells.
    Side effects: Liver/blood count effects, infection risks; regular lab monitoring needed.
    Note: These do not reverse a phthisical eye but may be vital to prevent further disease elsewhere.

---

Dietary molecular supplements

Supplements can support surface comfort and general eye health. They do not restore vision in phthisis bulbi. Discuss with your clinician, especially if pregnant, on blood thinners, or with kidney/liver disease.

1. Omega-3 (EPA/DHA) — 1000–2000 mg/day combined EPA+DHA
   Function: Supports tear oil layer and reduces surface inflammation.
   Mechanism: Anti-inflammatory lipid mediators.

2. Lutein + Zeaxanthin — Lutein 10 mg + Zeaxanthin 2 mg/day
   Function: Macular antioxidants for the seeing eye.
   Mechanism: Blue-light filtering; quenches free radicals.

3. Vitamin A (retinol or beta-carotene) — Use cautiously; avoid excess
   Function: Supports surface and conjunctival health.
   Mechanism: Maintains mucin-producing cells.
   Caution: Toxic in high doses; avoid in pregnancy unless prescribed.

4. Vitamin C — 500–1000 mg/day split
   Function: Collagen and antioxidant support.
   Mechanism: Scavenges reactive oxygen species.

5. Vitamin E — 200–400 IU/day
   Function: Lipid antioxidant; may protect cell membranes.
   Mechanism: Interrupts oxidative chain reactions.

6. Zinc (with copper) — Zinc 25–40 mg/day + Copper 2 mg/day if long-term
   Function: Enzyme cofactor; supportive for macular health.
   Mechanism: Involved in retinal enzyme systems.

7. N-Acetylcysteine (NAC) — 600 mg 1–2×/day
   Function: Mucolytic/antioxidant; may ease surface symptoms in dry eye.
   Mechanism: Precursor to glutathione; breaks mucus strands.

8. Curcumin (with piperine for absorption) — 500–1000 mg/day
   Function: Systemic anti-inflammatory support.
   Mechanism: Modulates NF-κB and cytokines.

9. Resveratrol — 100–250 mg/day
   Function: Antioxidant support; theoretical neuroprotection.
   Mechanism: Sirtuin pathways; anti-inflammatory signaling.

10. Coenzyme Q10 — 100–200 mg/day
    Function: Mitochondrial support and antioxidant.
    Mechanism: Electron transport and reactive oxygen scavenging.

Always prioritize food first (leafy greens, colorful vegetables, fish, nuts) and treat supplements as adjuncts.

---

Regenerative-oriented drugs

There are no proven “immunity boosters” or stem-cell drugs that reverse phthisis bulbi. However, in people whose phthisis came from severe uveitis or autoimmune disease, doctors may use the following immunomodulators to protect the other eye and control the underlying disease. Doses are specialist-guided with regular labs.

1. Methotrexate — weekly dosing (e.g., 7.5–25 mg/week) with folic acid
   Function: Steroid-sparing control of autoimmune eye inflammation.
   Mechanism: Inhibits folate pathways in rapidly dividing immune cells.

2. Mycophenolate mofetil — typically 500–1000 mg twice daily
   Function: Controls chronic uveitis with fewer steroid side effects.
   Mechanism: Blocks guanosine synthesis in lymphocytes.

3. Azathioprine — around 1–2 mg/kg/day
   Function: Long-term immune control in some uveitis types.
   Mechanism: Purine analogue that suppresses lymphocyte proliferation.

4. Cyclosporine — dose individualized; sometimes topical for surface disease
   Function: Reduces T-cell activation; helpful for severe ocular surface inflammation.
   Mechanism: Calcineurin inhibition.

5. Adalimumab (biologic anti-TNF) — subcutaneous per label
   Function: For non-infectious uveitis to reduce flares and steroid need.
   Mechanism: Neutralizes tumor necrosis factor-alpha.

6. Infliximab (biologic anti-TNF, IV) — infusion schedule per protocol
   Function: For selected refractory uveitis conditions.
   Mechanism: TNF-alpha blockade.

Experimental/under study: retinal or RPE stem-cell transplantation and autologous serum or platelet-rich plasma eye drops for surface healing. These do not reverse a shrunken globe and are not standard for phthisis bulbi.

---

Surgeries

1. Enucleation (removal of the eye) with orbital implant
   Procedure: The diseased eye is removed in the operating room. A ball implant is placed and muscles are attached to move it; later, a custom prosthetic eye is fitted.
   Why: Definitive pain relief, excellent cosmetic result, and elimination of inflammation sources or suspicion of hidden tumor.

2. Evisceration (removal of the eye’s inner contents) with implant
   Procedure: The shell of the eye (sclera) stays; inner contents are removed; an implant is placed; later, a prosthesis is fitted.
   Why: Pain relief and cosmesis when intraocular tumor is not suspected and the scleral shell is intact.

3. Cyclophotocoagulation (CPC) for painful high pressure
   Procedure: A laser or probe treats the ciliary body to reduce fluid production.
   Why: Decreases pressure-related pain in a blind eye when drops are not enough.

4. Retrobulbar neurolytic injection (bridge or alternative to surgery)
   Procedure: Alcohol or chlorpromazine is injected behind the eye to numb pain pathways.
   Why: Palliative pain control for patients not ready for removal surgery.

5. Tarsorrhaphy (partial eyelid closure)
   Procedure: The outer part of the eyelids is temporarily or permanently sewn partly closed.
   Why: Protects an exposed or dry cornea, reduces pain, and promotes surface healing.

Choice between enucleation and evisceration depends on anatomy, infection risk, tumor concern, and patient preference. Both usually allow a natural-looking prosthetic eye afterwards.

---

Prevention strategies

These steps cannot reverse phthisis but can reduce the chance of ever reaching this stage.

1. Seek urgent care for eye injuries (cuts, blunt trauma, foreign bodies).

2. Treat severe infections and corneal ulcers promptly.

3. Control uveitis early with the right steroid and steroid-sparing plan.

4. Repair retinal detachments quickly when possible.

5. Manage glaucoma and keep follow-ups to prevent pressure damage.

6. Wear certified eye protection at work, sports, and home projects.

7. Flush chemical exposures immediately and get emergency care.

8. Avoid non-prescribed eye drops or traditional remedies that may be toxic.

9. Control systemic autoimmune diseases (e.g., rheumatoid arthritis, sarcoidosis).

10. Keep regular eye checkups if you have a history of eye surgery or trauma.

---

When to see a doctor

• Seek urgent/emergency eye care today if you have sudden severe pain, eye redness with discharge, a new visible white spot on the cornea, trauma/chemical splash, sudden vision change in the other eye, fever with deep eye pain, or a rapidly shrinking/painful blind eye.

• Make a prompt appointment if the phthisical eye becomes more uncomfortable, more cosmetically disturbing, or if you want to discuss prosthesis or surgery.

• Routine follow-up is important to protect the healthy eye and to maintain prosthesis fit and eyelid health.

---

What to eat and what to avoid

What to eat (10 ideas):

1. Leafy greens (spinach, kale) for lutein/zeaxanthin.

2. Fatty fish (salmon, sardines) 2–3×/week for omega-3s.

3. Colorful vegetables (carrots, peppers) for carotenoids.

4. Citrus and berries for vitamin C.

5. Nuts and seeds (almonds, sunflower) for vitamin E and healthy fats.

6. Legumes and lean proteins for tissue repair.

7. Whole grains for steady energy and micronutrients.

8. Hydration—water or unsweetened tea to support tear film.

9. Tomatoes for lycopene (antioxidant).

10. Dairy or fortified alternatives for vitamin A (within safe limits).

What to limit/avoid (10 reminders):

1. Smoking and vaping (strongly avoid).

2. Excess alcohol (dries the surface and impacts healing).

3. Very salty foods (can worsen dehydration).

4. Ultra-processed snacks high in refined sugar/fats (promote inflammation).

5. Megadoses of vitamin A without medical advice.

6. Unverified herbal eye drops or home-made solutions.

7. Chili fumes or harsh solvents near the face (irritants).

8. Energy drinks in excess (sleep disruption worsens pain).

9. Dehydration—don’t skip fluids.

10. Allergy-trigger foods if you know they worsen eye itch/rub behavior.

---

Frequently asked questions (FAQs)

1) Can vision come back in a phthisical eye?
No. Phthisis bulbi is an end-stage condition with irreversible structural damage. Treatment focuses on comfort, appearance, and safety.

2) Is phthisis bulbi dangerous to my overall health?
The eye itself is not dangerous, but it can be painful or inflamed, and very rarely it can hide problems that need evaluation. Protect your healthy eye diligently.

3) Will glasses or contact lenses help me see from that eye again?
No. Optical lenses cannot overcome the severe internal scarring and tissue loss.

4) Why does my phthisical eye hurt if it’s blind?
Damaged nerves, residual inflammation, surface dryness, or abnormal pressure can all cause pain. These are treatable even if vision cannot be restored.

5) What is the difference between enucleation and evisceration?
Enucleation removes the whole globe; evisceration removes inner contents but leaves the scleral shell. Both allow a prosthetic eye and relieve pain; choice depends on your situation.

6) Will a prosthetic eye move?
Yes, a modern prosthesis over an implant usually moves naturally with your other eye, though not as fully.

7) Can leaving a painful blind eye in place harm my good eye?
Rarely, long-standing inflammation after penetrating trauma can predispose to sympathetic ophthalmia in the fellow eye. Your specialist weighs this risk when advising surgery.

8) Are “stem cell cures” available now?
Not for phthisis bulbi. Stem-cell and retinal implants are experimental and target specific diseases; they do not rebuild a fully shrunken eye.

9) Do supplements cure phthisis?
No. Supplements can support comfort and general eye health but cannot reverse structural loss.

10) How soon after injury can phthisis develop?
It varies—months to years—depending on the original damage and control of inflammation or infection.

11) Will insurance cover prosthetic eyes?
Often yes, but coverage varies. A board-certified ocularist and your insurer can verify benefits.

12) Can I swim or shower with a prosthetic eye?
Usually yes, but avoid dirty water and follow your ocularist’s cleaning routine to prevent infections or deposits.

13) How often should the prosthesis be polished or replaced?
Polishing is often every 6–12 months; replacement typically every 3–5 years (varies by materials and comfort).

14) What if I’m not ready for surgery but the eye hurts a lot?
Options include aggressive lubrication, pain medications, IOP control, CPC, or retrobulbar alcohol/chlorpromazine to numb pain.

15) How do I protect my good eye long-term?
Wear safety glasses, keep regular eye exams, manage any systemic disease, and seek care early for new symptoms.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 21, 2025.